Company intelligence / Profile preview

GCM Pharma

Ownership: Private
Development stage: Preclinical

Overview

GCM Pharma is a US-based contract development and manufacturing organization specializing in small-scale clinical manufacturing and commercial fill-finish services for biologics and small molecules. The company offers cGMP Annex 1 compliant facilities with advanced isolator technology, supporting clients from early-stage formulation through commercialization. Services include analytical chemistry/microbiology testing, regulatory filing support, labeling/packaging design, clinical trial repackaging, temperature-controlled storage/distribution, and flexible automated filling solutions suitable for vials, syringes or cartridges.

Modalities: BiologicSmall molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on GCM Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GCM Pharma.

Explore the full profile